Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells
2008
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
2009
microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma
2010
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
2007
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
2016
Phase‐separated foci of EML4‐ALK facilitate signalling and depend upon an active kinase conformation
2021
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
Triple-Negative Breast Cancer
2010 Standout
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
2008 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
MYC on the Path to Cancer
2012 Standout
COPS: A Sensitive and Accurate Tool for Detecting Somatic Copy Number Alterations Using Short-Read Sequence Data from Paired Samples
2012
Hepatocellular carcinoma
2016 Standout
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Disparities in cancer outcomes: Lessons learned from children with cancer
2011
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Cancer drug resistance: an evolving paradigm
2013 Standout
Thymoquinone and its therapeutic potentials
2015 Standout
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
2017 Standout
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Epigenetics in cancer
2009 Standout
Oncogenic mutations of ALK kinase in neuroblastoma
2008 Nature
MicroRNAs in cancer: biomarkers, functions and therapy
2014 Standout
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
2007
Drug repurposing: progress, challenges and recommendations
2018 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation
2011
Ceramide-orchestrated signalling in cancer cells
2012
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
2012
Recent Advances in Neuroblastoma
2010
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
2012
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
2010
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis
2007 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Neuroblastoma
2007 Standout
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
2009 Standout
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
2010
The MYCN oncogene is a direct target of miR-34a
2008
Digital pathology and artificial intelligence
2019 Standout
A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites
2011
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
2012
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Identification of copy number variants in whole-genome data using Reference Coverage Profiles
2015 StandoutNobel
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Childhood and adolescent cancer statistics, 2014
2014 Standout
Targeting MYC-Regulated miRNAs to Combat Cancer
2010
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine
2015
Cutadapt removes adapter sequences from high-throughput sequencing reads
2011 Standout
Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling
2017
Early fault diagnosis of bearing and stator faults of the single-phase induction motor using acoustic signals
2017 Standout
A Tool for Decision Making in K-Out-of-N System Maintenance
2011
Drug Resistance in Cancer: An Overview
2014 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Outcome of Photodynamic Therapy Using NPe6 for Bronchogenic Carcinomas in Central Airways >1.0 cm in Diameter
2010
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
2007
Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?
2005
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Patrick McGrady being referenced
Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
2009
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
2014
Influence of neuroblastoma stage on serum‐based detection of MYCN amplification
2009
Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:rs1800795(Promoter) andrs8192284(Receptor)
2009
Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study
2010
Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group
2011
Chromosome arm 11q deletion predicts for neuroblastoma outcome: A Children’s Oncology Group study
2005
Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses
2008
The Availability of a k-out-of-n:G Network
1985
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group
2013
Racial and ethnic disparities in disease presentation and survival among children with neuroblastoma (NBL): A Children's Oncology Group (COG) study.
2010